 |
Memo Therapeutics
Last updated: October 10, 2024
Founder Christoph Esslinger
Switzerland | Funding: $108.8M (+)
Website: https://memo-therapeutics.com/home.html
Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
Website: https://memo-therapeutics.com/home.html
Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
